The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
The proinflammatory cytokine interleukin-17 (IL-17) is the signature cytokine of the T helper 17 (TH17) subset of CD4(+) T cells, and antibodies targeting IL-17 or the IL-17 receptor (IL-17R) show clinical efficacy in several autoimmune diseases. Although important for protective immunity against microorganisms, IL-17 causes collateral damage in inflammatory settings. TNFAIP3 encodes the deubiquitinase A20 and is genetically linked to numerous autoimmune syndromes. A20, a potent inhibitor of tumor necrosis factor-α signaling, removes ubiquitin from signaling intermediates upstream of nuclear factor κB (NF-κB), thereby dampening NF-κB-mediated inflammation. We demonstrated that IL-17 stimulates TNFAIP3 expression. Enhanced IL-17-mediated induction of genes encoding proinflammatory factors, including IL-6 and various chemokines, occurred upon knockdown of A20 with short inhibitory RNA or in A20(-/-) cells. A20 associated with the E3 ubiquitin ligase TRAF6 (tumor necrosis factor receptor-associated factor 6) in an IL-17-dependent manner and restricted the IL-17-dependent activation of NF-κB and mitogen-activated protein kinases. A20 interacted directly with the distal domain of IL-17RA, a previously defined inhibitory domain. Together, these data describe a mechanism of restraining IL-17 signaling and reveal an aspect of A20 activity that may help to explain its role in autoimmunity in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Garg et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 2×
“IL-17 is produced by a subset of CD4 T cells termed T helper 17 (TH17) cells, and a fast-moving body of literature has described the many mechanisms by which TH17 cells are generated and regulated (6, 7).”
BackgroundHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039 · cited 1×
“Conversely, excess IL-17 is associated with numerous autoimmune diseases, and many genes identified as risk loci for autoimmunity in genome-wide association studies (GWAS) (for example, IL23R and STAT3) are associated with regulation of IL-17 or the TH17 differentiation pathway (13, 14).”
BackgroundCytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529 · cited 1×
“Inflammatory cytokines, such as tumor necrosis factor–a (TNF-a), have long been recognized to promote the pathogenesis of devastating autoimmune diseases, such as rheumatoid arthritis (RA), among many others (1).”
BackgroundDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856 · cited 3×
“The primary enzymatic function of A20 is to serve as a DUB, although it can also act as a ubiquitin ligase and inhibit signaling independently of its catalytic activity (32, 36, 55, 80).”
BackgroundSelf-citationIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 1×
“Since the discovery of the TH17 subset of helper T cells in 2005, considerable attention has been paid to how TH17 and other IL-17–producing cells are generated and maintained but far less to how IL-17 mediates downstream signaling (6, 62).”
BackgroundInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475 · cited 8×
“A20 inhibits the IL-17–dependent activation of MAPK signaling, particularly the c-Jun N-terminal kinase pathway In the IL-17 signaling pathway, TRAF6 is required for the activation of MAPKs (15).”
BackgroundSelf-citationFailure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409 · cited 20×
“Cell cultures, reagents, and luciferase assays A20 and TRAF6 MEFs were cultured in a-MEM (minimum essential medium, Sigma) containing 10% fetal bovine serum (FBS) supplemented with L-glutamine and antibiotics (Invitrogen) (39).”
BackgroundMethodResultSelf-citationFunctional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289 · cited 2×
“In turn, Act1 recruits and activates TNF receptor– associated factor 6 (TRAF6), ultimately leading to the activation of transcription factors, such as NF-kB, C/EBPb, and C/EBPd, as well as of MAPKs (21, 22).”
BackgroundFate mapping of IL-17-producing T cells in inflammatory responses
Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1993 · Cited by 1,176
Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs
Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.007 · Cited by 1,136
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090 · cited 1×
“Subsequent studies identified roles for A20 in inhibiting the TLR, IL-1R, and Nod-like receptor (NLR) pathways (32, 37, 38).”
BackgroundSelf-citationHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Self-citationHueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Shembade, N., Ma, A., & Harhaj, E. W. (2010) · Science · doi:10.1126/science.1182364 · Cited by 643 · cited 5×
“S3) (32), the best characterized of which is the N-terminal OTU (ovarian tumor) domain, which encodes DUB activity and is proposed to be important for the association of A20 with TRAF6 (55, 56).”
BackgroundSelf-citationMaddur, M. S., Miossec, P., Kaveri, S. V., & Bayry, J. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.03.044 · Cited by 619
Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 4×
“The SEFIR domain is conserved among IL-17R family members and serves as a platform for its association with Act1, which in turn interacts with TRAF6 (19).”
BackgroundMethodInfluentialA20: linking a complex regulator of ubiquitylation to immunity and human disease
Ma, A., & Malynn, B. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3313 · Cited by 548
Self-citationMusone, S. L., Taylor, K. E., Lu, T. T., Nititham, J., Ferreira, R. C., Ortmann, W., Shifrin, N., Petri, M. A., Ilyas Kamboh, M., Manzi, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.202 · Cited by 470
Self-citationGenovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P., & Sloan‐Lancaster, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27334 · Cited by 451
Krikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444 · cited 2×
“A20 inhibits IL-17 signaling As its name implies, TNFAIP3 was first identified as a TNF-a–induced gene (44), and its gene product A20 serves as a feedback inhibitor of NF-kB (39).”
BackgroundSong, H. Y., Rothe, M., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6721 · Cited by 414
IL-25 regulates Th17 function in autoimmune inflammation
Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B., Langrish, C. L., Chen, Y., Gorman, D. M., Blumenschein, W. M., McClanahan, T., Brombacher, F., Hurst, S. D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061738 · Cited by 396
Zhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., Liang, D., He, D., Wang, H., Liu, W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2815 · Cited by 396 · cited 1×
“A report also implicates the microRNAmiR-23b in limiting IL-17 activity (75).”
BackgroundRuddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364 · cited 7×
“MAPK activation leads to AP-1 activation, and AP-1 binding sites are statistically overrepresented in the promoters of IL-17 target genes (50); however, at least for the Il6 promoter, the AP-1 binding site is dispensable for IL-17–induced activation (46).”
BackgroundMethodSelf-citationAct1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor
Chang, S. H., Park, H., & Dong, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600256200 · Cited by 356 · cited 1×
“As a positive control, we used siRNA specific for Act1, an adaptor protein required for IL-17R signaling (18, 19).”
MethodDeubiquitylation and regulation of the immune response
Sun, S.-C. (2008) · Nature Reviews Immunology · doi:10.1038/nri2337 · Cited by 355
The role of ubiquitylation in immune defence and pathogen evasion
Jiang, X., & Chen, Z. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3111 · Cited by 353 · cited 1×
“Ubiquitination is a posttranslational modification that is essential for modulating proinflammatory pathways (27).”
BackgroundSchwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349
Hitotsumatsu, O., Ahmad, R.-C., Tavares, R., Wang, M., Philpott, D., Turer, E. E., Lee, B. L., Shiffin, N., Advincula, R., Malynn, B. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.002 · Cited by 347 · cited 1×
“Subsequent studies identified roles for A20 in inhibiting the TLR, IL-1R, and Nod-like receptor (NLR) pathways (32, 37, 38).”
BackgroundSelf-citationReturn to homeostasis: downregulation of NF-κB responses
Ruland, J. (2011) · Nature Immunology · doi:10.1038/ni.2055 · Cited by 322
Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells
Wright, J. F., Guo, Y., Quazi, A., Luxenberg, D. P., Bennett, F., Ross, J. F., Qiu, Y., Whitters, M. J., Tomkinson, K. N., Dunussi-Joannopoulos, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700499200 · Cited by 319
The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex
Wright, J. F., Bennett, F., Li, B., Brooks, J., Luxenberg, D. P., Whitters, M. J., Tomkinson, K. N., Fitz, L. J., Wolfman, N. M., Collins, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2799 · Cited by 316
Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes
Shen, F., Hu, Z., Goswami, J., & Gaffen, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604597200 · Cited by 294
Self-citationMatmati, M., Jacques, P., Maelfait, J., Verheugen, E., Kool, M., Sze, M., Geboes, L., Louagie, E., Guire, C. M., Vereecke, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.874 · Cited by 290 · cited 1×
“Moreover, polymorphisms in the TNFAIP3 locus are associated with increased susceptibility to RA, lupus, systemic sclerosis, Crohn’s disease, and psoriasis (41, 43).”
BackgroundThe functional plasticity of T cell subsets
Bluestone, J. A., Mackay, C. R., O'Shea, J. J., & Stockinger, B. (2009) · Nature Reviews Immunology · doi:10.1038/nri2654 · Cited by 285
A Strategy for Modulation of Enzymes in the Ubiquitin System
Ernst, A., Avvakumov, G., Tong, J., Fan, Y., Zhao, Y., Alberts, P., Persaud, A., Walker, J. R., Neculai, A.-M., Neculai, D., et al. (2013) · Science · doi:10.1126/science.1230161 · Cited by 283
Recent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283 · cited 1×
“IL-17 is the founding member of a distinct subclass of cytokines and receptors that exhibit distinct signaling properties compared to those of the better-defined cytokine receptors, such as the TNF receptor (TNFR) superfamily or the IL-1 receptor (IL-1R) and Toll-like receptor (TLR) families (9).”
BackgroundSelf-citationA novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses
Chang, S. H., & Dong, C. (2007) · Cell Research · doi:10.1038/cr.2007.35 · Cited by 280
Shen, F., Ruddy, M. J., Plamondon, P., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904490 · Cited by 268
Self-citationMiossec, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10816 · Cited by 264
Shen, F., & Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.013 · Cited by 256
Self-citationThe STIR-domain superfamily in signal transduction, development and immunity
Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubüser, A., & Eisenhaber, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00067-7 · Cited by 255 · cited 2×
“Like most receptors, IL-17RA contains discrete functional subdomains (16, 23).”
BackgroundDirect, Noncatalytic Mechanism of IKK Inhibition by A20
Skaug, B., Chen, J., Du, F., He, J., Ma, A., & Chen, Z. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.015 · Cited by 251 · cited 1×
“The primary enzymatic function of A20 is to serve as a DUB, although it can also act as a ubiquitin ligase and inhibit signaling independently of its catalytic activity (32, 36, 55, 80).”
BackgroundSelf-citationHammer, G. E., Turer, E. E., Taylor, K. E., Fang, C. J., Advincula, R., Oshima, S., Barrera, J., Huang, E. J., Hou, B., Malynn, B. A., et al. (2011) · Nature Immunology · doi:10.1038/ni.2135 · Cited by 243
Self-citationIL-17 family member cytokines: Regulation and function in innate immunity
Reynolds, J. M., Angkasekwinai, P., & Dong, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.002 · Cited by 235
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Gaffen, S. L. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0052-y · Cited by 235 · cited 1×
“Increased amounts of IL-17 and an increase in the extent of expression of IL-17–induced genes are associated with pathology in RA (49).”
BackgroundSelf-citationSpecific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF‐κB regulation
Tokunaga, F., Nishimasu, H., Ishitani, R., Goto, E., Noguchi, T., Mio, K., Kamei, K., Ma, A., Iwai, K., & Nureki, O. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.241 · Cited by 235 · cited 1×
“In addition, the seven C-terminal zinc finger (ZnF) domains are important for A20 activity (32, 55, 57, 58).”
BackgroundSelf-citationAct1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224 · cited 3×
“In the IL-17 signaling pathway, TRAF6 is required for the activation of MAPKs (15).”
BackgroundExpression, biological activities and mechanisms of action of A20 (TNFAIP3)
Verstrepen, L., Verhelst, K., van Loo, G., Carpentier, I., Ley, S. C., & Beyaert, R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.044 · Cited by 219 · cited 3×
“A20 is a deubiquitinase (DUB) and tumor suppressor encoded by TNFAIP3 (TNF-a–induced protein 3) and was first identified as an inhibitor of the TNFR signaling pathway (35, 36).”
BackgroundRegulation of NF-κB signaling by the A20 deubiquitinase
Shembade, N., & Harhaj, E. W. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.59 · Cited by 211 · cited 2×
“A20 is a deubiquitinase (DUB) and tumor suppressor encoded by TNFAIP3 (TNF-a–induced protein 3) and was first identified as an inhibitor of the TNFR signaling pathway (35, 36).”
BackgroundZhong, B., Liu, X., Wang, X., Chang, S. H., Liu, X., Wang, A., Reynolds, J. M., & Dong, C. (2012) · Nature Immunology · doi:10.1038/ni.2427 · Cited by 206
Verhelst, K., Carpentier, I., Kreike, M., Meloni, L., Verstrepen, L., Kensche, T., Dikic, I., & Beyaert, R. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.240 · Cited by 203 · cited 1×
“In addition, the seven C-terminal zinc finger (ZnF) domains are important for A20 activity (32, 55, 57, 58).”
BackgroundUbiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling
Bosanac, I., Wertz, I. E., Pan, B., Yu, C., Kusam, S., Lam, C., Phu, L., Phung, Q., Maurer, B., Arnott, D., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.009 · Cited by 190
Advances in understanding the anti-inflammatory properties of IL-27
Stumhofer, J. S., & Hunter, C. A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.01.011 · Cited by 172
Heyninck, K., & Beyaert, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01645-7 · Cited by 169
Lopez-Castejon, G., Luheshi, N. M., Compan, V., High, S., Whitehead, R. C., Flitsch, S., Kirov, A., Prudovsky, I., Swanton, E., & Brough, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422238 · Cited by 168
Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165
Self-citationCIKS, a connection to IκB kinase and stress-activated protein kinase
Leonardi, A., Chariot, A., Claudio, E., Cunningham, K., & Siebenlist, U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190245697 · Cited by 160
Ubiquitin Makes Its Mark on Immune Regulation
Malynn, B. A., & Ma, A. (2010) · Immunity · doi:10.1016/j.immuni.2010.12.007 · Cited by 149 · cited 3×
“The NF-kB pathway is intricately regulated by ubiquitination and deubiquitination reactions (28).”
BackgroundSelf-citationIL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 146
Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy
Huppler, A. R., Bishu, S., & Gaffen, S. L. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3893 · Cited by 143
Self-citationInborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Puel, A., Picard, C., Cypowyj, S., Lilic, D., Abel, L., & Casanova, J.-L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.009 · Cited by 140
Zhu, S., Pan, W., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 138
Unraveling the Genetics of Autoimmunity
Zenewicz, L. A., Abraham, C., Flavell, R. A., & Cho, J. H. (2010) · Cell · doi:10.1016/j.cell.2010.03.003 · Cited by 133 · cited 1×
“Conversely, excess IL-17 is associated with numerous autoimmune diseases, and many genes identified as risk loci for autoimmunity in genome-wide association studies (GWAS) (for example, IL23R and STAT3) are associated with regulation of IL-17 or the TH17 differentiation pathway (13, 14).”
BackgroundIL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain
Shen, F., Li, N., Gade, P., Kalvakolanu, D. V., Weibley, T., Doble, B., Woodgett, J. R., Wood, T. D., & Gaffen, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000066 · Cited by 131
Self-citationHo, A. W., Shen, F., Conti, H. R., Patel, N., Childs, E. E., Peterson, A. C., Hernández-Santos, N., Kolls, J. K., Kane, L. P., Ouyang, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903739 · Cited by 125
Self-citationCytokines that regulate autoimmunity
Diveu, C., McGeachy, M. J., & Cua, D. J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.09.003 · Cited by 103 · cited 1×
“Hence, it is not surprising that there are numerous mechanisms in place to constrain the activities of IL-17 and TH17 cells (63, 64).”
BackgroundA20 (Tnfaip3) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection
Maelfait, J., Roose, K., Bogaert, P., Sze, M., Saelens, X., Pasparakis, M., Carpentier, I., van Loo, G., & Beyaert, R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002570 · Cited by 92
IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence
Datta, S., Novotny, M., Pavicic, P. G., Zhao, C., Herjan, T., Hartupee, J., & Hamilton, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902423 · Cited by 82
Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
Li, X.-X. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.015 · Cited by 78 · cited 1×
“For example, the E3 ligase activity of Act1 is required for the K(63) ubiquitination of TRAF6, which is also an E3 ubiquitin ligase (17, 29, 30).”
BackgroundHuang, Q., & Pope, R. M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310126 · Cited by 76
Klinkenberg, M., Huffel, S. V., Heyninck, K., & Beyaert, R. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02504-2 · Cited by 68 · cited 2×
“In particular, ZnF4 andZnF5 exhibit ubiquitin binding activity,which facilitates adaptor recruitment and substrate recognition (59, 60).”
BackgroundMethodTNFα-induced macrophage death via caspase-dependent and independent pathways
Tran, T. M., Temkin, V., Shi, B., Pagliari, L. J., Daniel, S., Ferran, C. J., & Pope, R. M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0311-4 · Cited by 60
SEF/IL-17R (SEFIR) Is Not Enough
Onishi, R. M., Park, S. J., Hanel, W., Ho, A. W., Maitra, A., & Gaffen, S. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121418 · Cited by 56
Self-citationNegative regulation of Th17 responses
Stumhofer, J. S., Silver, J., & Hunter, C. A. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.006 · Cited by 52 · cited 1×
“Hence, it is not surprising that there are numerous mechanisms in place to constrain the activities of IL-17 and TH17 cells (63, 64).”
BackgroundShi, P., Zhu, S., Lin, Y., Liu, Y., Liu, Y., Chen, Z., Shi, Y., & Qian, Y. (2011) · Science Signaling · doi:10.1126/scisignal.2001653 · Cited by 50
Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression
Hamilton, T., Novotny, M., Pavicic, P. J., Herjan, T., Hartupee, J., Sun, D., Zhao, C., & Datta, S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.04.003 · Cited by 36 · cited 1×
“The basis for this difference is not clear; however, IL-17 also regulates the stability of many target mRNAs (81).”
BackgroundA Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling
Lindén, A. (2007) · Science's STKE · doi:10.1126/stke.3982007re4 · Cited by 35 · cited 1×
“For example, the E3 ligase activity of Act1 is required for the K(63) ubiquitination of TRAF6, which is also an E3 ubiquitin ligase (17, 29, 30).”
BackgroundAbdollahi‐Roodsaz, S., van de Loo, F. A. J., Koenders, M. I., Helsen, M. M. A., Walgreen, B., van den Bersselaar, L. A., Arntz, O. J., Takahashi, N., Joosten, L. A. B., & van den Berg, W. B. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34328 · Cited by 22 · cited 1×
“Clearly, this is related in part through the inhibition of TNF-dependent signaling by A20 (83); however, A20 also constrains TLR and NLR signaling, which are increasingly recognized as important in mediating autoimmunity (84, 85).”
Background
Cited by
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Self-citationThe IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Conversely, IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25 (Cruz et al., 2017; Garg et al., 2013; Zhong et al., 2012) (Figure 4).”
BackgroundSelf-citationIL-17 and IL-17-producing cells in protection versus pathology
Mills, K. H. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00746-9 · Cited by 1,000
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“In the IL-17 pathway, A20 (encoded by Tnfaip3, a common autoimmune gene locus [99]) and Usp25 have both been shown to deubiquitinate TRAFs (Figure 4) [42, 103].”
BackgroundSelf-citationNF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Dorrington, M. G., & Fraser, I. D. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00705 · Cited by 717
“Moreover, even in the presence of continued stimulation, negative regulation via deubiquitinases like A20 can arrest signaling by deubiquitinating both components of the IKK complex (38) and important signaling proteins such as TRAF6 (39).”
Background
Metadata
- Authors
- Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Science Signaling
- Published
- 2013-06-04
- Volume
- 6
- Issue
- 278
- Pages
- ra44-ra44
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC4028484
- OpenAlex
- W2103961090
- Cited by
- 128
- References
- 88
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 8 · 2021: 9 · 2020: 14 · 2019: 13 · 2018: 11 · 2017: 12 · 2016: 11 · 2015: 6 · 2014: 12 · 2013: 6
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK095693, P30DK026743)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- A20, IL-17, IL-17 receptor signaling, TRAF6, E3 ubiquitin ligase, NF-κB activation, product inhibition, inflammatory cytokines, interleukin-6, chemokines, mitogen-activated protein kinase, autoimmunity, Th17 cells
- MeSH terms
- Humans, Promoter Regions, Genetic, Signal Transduction, NF-kappa B, TNF Receptor-Associated Factor 6, Receptors, Interleukin-17, Ubiquitin-Specific Proteases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.